Diagnostics News and Research

RSS

ADDF supports the need to gather more evidence about clinical effectiveness of anti-amyloid drug

On Thursday, April 7, the Centers for Medicare and Medicaid (CMS) formalized its plan to cover the anti-amyloid drug Aduhelm only for patients enrolled in clinical trials.

8 Apr 2022

SARS-CoV-2 detected using smartphone biosensor

Researchers describe the use of RT-LAMP in combination with particle diffusometry to detect SARS-CoV2 in saliva samples.

7 Apr 2022

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

A University of Georgia nanotechnology research group entered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American manufacturing company.

7 Apr 2022

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

A recent study analyzed the antibody that mediated the COVID-19 vaccine-induced thrombotic thrombocytopenia.

7 Apr 2022

Creation of immunosuppressive environment is key to the progression of colorectal cancer development

Interactions between cells of the immune system and pre-cancerous cells are known to be important contributing factors to the initiation and progression of cancer.

7 Apr 2022

Wastewater-based Epidemiology technique can help move toward a healthier and more sustainable world

Of the many contemporary conveniences often taken for granted in developed countries, modern sanitation may be among the most important. A new study suggests that wastewater infrastructure may provide societal benefits far beyond the dramatic improvements in community hygiene.

6 Apr 2022

Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.

From Sino Biological Inc. 6 Apr 2022

Health and Social Care Levy to raise billions to tackle Covid backlogs and reform adult social care

From Wednesday 6 April, the Health and Social Care Levy will come into effect and begin to raise billions to help tackle the Covid backlogs and reform the adult social care system.

5 Apr 2022

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.

4 Apr 2022

Arrayjet introduces Mercury range of next-generation microarray printers

Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing.

From Arrayjet Ltd 4 Apr 2022

Novel rapid genetic test could spare 14,000 newborns from lifelong hearing loss

Clinicians and nurses in neonatal intensive care units (NICU) across Manchester University NHS Foundation Trust (MFT) are the world’s first to deploy genedrive’s MT-RNR1 ID Kit, a new rapid genetic point of care test (POCT) to screen babies for the genetic variant m.1555A>G when admitted with suspected sepsis

4 Apr 2022

Smart toilets for passive surveillance of SARS-CoV-2

In a recent study published in Nature Digital Medicine, researchers highlighted a potential strategy for using a smart toilet platform, Coronavirus: Integrated Diagnostic (COV-ID), for passive monitoring of coronavirus disease 2019 (COVID-19).

3 Apr 2022

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Scientists discuss the pathogenic characteristics of SARS-CoV-2 and available therapeutic interventions for treating COVID-19.

3 Apr 2022

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

2 Apr 2022

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

In a paper in the journal Nature, Los Alamos National Laboratory scientists Bette Korber, Hyejin Yoon, Will Fischer and James Theiler, among nearly 130 authors from institutions around the world, describe their groundbreaking collaborative work, "Defining the risk of SARS-CoV-2 variants on immune protection."

1 Apr 2022

Implant placed alongside a blood vessel could replace bulkier devices that stimulate nerves

An implant little bigger than a grain of rice, put gently in place alongside a strategically placed blood vessel, could replace much bulkier devices that stimulate nerves.

31 Mar 2022

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

A new study has found that the Novaplex SARS-CoV-2 Variant I, II, and IV real-time PCR assays (from Seegene Technology) can reliably detect SARS-CoV-2 in patient samples and identify known variants of interest and concern.

31 Mar 2022

Study examines pediatric emergency department attendance trends during the first COVID-19 wave in Europe

Researchers investigated the impact of SARS-CoV-2 infection and the adoption of preventive measures in pediatric emergency department attendances in Europe.

30 Mar 2022

New test predicts sepsis well before blood clotting and organ failure

In a potential paradigm change for sepsis diagnostics, a new test predicted sepsis soon after infection in mice - well before blood clotting and organ failure - enabling early antibiotic treatment and markedly increased survival.

29 Mar 2022

FDA requests nearly 34% increase in funding as part of the President’s fiscal year 2023 budget

Today, the U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President's fiscal year (FY) 2023 budget - a nearly 34% ($2.1 billion) increase over the agency's FY 2022 appropriated funding level for investments in critical public health modernization, core food safety and medical product safety programs and other vital public health infrastructure.

29 Mar 2022

Diagnostics News and Research

ADDF supports the need to gather more evidence about clinical effectiveness of anti-amyloid drug

SARS-CoV-2 detected using smartphone biosensor

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

Creation of immunosuppressive environment is key to the progression of colorectal cancer development

Wastewater-based Epidemiology technique can help move toward a healthier and more sustainable world

Developing and manufacturing custom recombinant antibodies for R&D

Health and Social Care Levy to raise billions to tackle Covid backlogs and reform adult social care

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

Arrayjet introduces Mercury range of next-generation microarray printers

Novel rapid genetic test could spare 14,000 newborns from lifelong hearing loss

Smart toilets for passive surveillance of SARS-CoV-2

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Implant placed alongside a blood vessel could replace bulkier devices that stimulate nerves

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Study examines pediatric emergency department attendance trends during the first COVID-19 wave in Europe

New test predicts sepsis well before blood clotting and organ failure

FDA requests nearly 34% increase in funding as part of the President’s fiscal year 2023 budget

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News